Cite
HARVARD Citation
Liu, L. et al. (2022). Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase III trial FIRE‐3 (AIO KRK‐0306). International journal of cancer. 150 (1), pp. 112-123. [Online].